,,ii  #aag? ,,congress  #b;d ,session   
,s4 #cdgh  ,,9 ,,! ,,s5ate ,,( ,,!      
,,unit$ ,,/ates  ,janu>y #aa            
7legislative day1 ,janu>y #aj71         
#bjbb,mr4 ,casey 7= himself1 ,mr4       
,cassidy1 & ,mr4 ,murphy7 introduc$ !   
foll[+ bill2 :i* 0 read twice & ref]r$  
to ! ,committee on ,heal?1 ,education1  
,labor1 & ,p5sions  ,a ,,bill  ,to      
provide = ! designation ( biological    
products z qualifi$ infecti\s disease   
products4  #a4 ,%ort title ,?is ,act may
 be cit$ z ! ,g5]at+ ,antibiotic        
,inc5tives ,n[ ,?r\gh ,op5+             
,opportunities to ,lev]age ,sci5ce ,act 
( #bjbb or ! ,,ga9 ,,tools ,act ( #bjbb4
  #b4 ,exp&+ qualifi$ infecti\s disease 
products to include biological products 
7a7 ,9 g5]al ,section #eje;,e ( ! ,f$]al
 ,food1 ,drug1 & ,cosmetic ,act 7#ba    
,u4,s4,c4 #cee;f7 is am5d$-- 7#a7 9     
subsection 7c7-- 7,a7 9 p>agraph 7#b71  
by /rik+ 2 or & ins]t+ 22  7,b7 9       
p>agraph 7#c71 by /rik+ ! p]iod & ins]t+
 2 or2 &  7,c7 by add+ at ! end !       

foll[+3  7#d7 an application pursuant to
 section #cea7;a7 ( ! ,public ,heal?    
,s]vice ,act4  2  7#b7 9 subsection     
7d77#a71 by ins]t+ ( ?is ,act or section
 #cea7;a7 ( ! ,public ,heal? ,s]vice    
,act aft] section #eje7;b72 &  7#c7 by  
am5d+ subsection 7g7 to read z foll[s3  
7g7 ,qualifi$ infecti\s disease product 
,! t]m qualifi$ infecti\s disease       
product means a drug or biological      
product = human use t-- 7#a7 is-- 7,a7  
an antibact]ial or antifungal drug2 or  
7,b7 a biological product t acts        
directly on bact]ia or fungi or on      
sub/ances produc$ by su* bact]ia or     
fungi2 &  7#b7 is int5d$ to treat a     
s]i\s or life-?reat5+ infection1 includ+
 su* an infection caus$ by-- 7,a7 an    
antibact]ial or antifungal resi/ant     
pa?og51 includ+ novel or em]g+ infecti\s
 pa?og5s2 or  7,b7 qualify+ pa?og5s li/$
 by ! ,secret>y "u subsection 7f74  4   
7b7 ,priority review ,section #ebd;,a7a7
 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic   
,act 7#ba ,u4,s4,c4 #cfjn-#a7;a77 is    

am5d$ by ins]t+ ( ?is ,act1 or section  
#cea7;a7 ( ! ,public ,heal? ,s]vice     
,act1 t requires cl9ical data 7o!r ?an  
bioavailability /udies7 to demon/rate   
safety or effectiv5ess be=e ! p]iod4